ask="7.00"
ask_size="500"
average_daily_volume="52574"
bid="2.60"
bid_size="200"
book_value="1.28"
change="-0.03"
change_from_200_day_moving_average="0.13"
change_from_50_day_moving_average="0.32"
change_from_52_week_high="-3.67"
change_From_52_week_low="1.27"
change_in_percent="-0.74%"
close="4.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.38"
ebitda="-15.34M"
eps_estimate_current_year="-1.39"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="6708000"
high="4.10"
high_52_weeks="7.72"
last_trade_date="1/30/2017"
last_trade_price="4.05"
last_trade_size="100"
last_trade_time="4:00pm"
low="3.95"
low_52_weeks="2.78"
market_capitalization="49.20M"
moving_average_200_day="3.92"
moving_average_50_day="3.73"
name="Galmed Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="13.40"
open="4.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+3.23%"
percent_change_from_50_day_moving_average="+8.62%"
percent_change_from_52_week_high="-47.54%"
percent_change_from_52_week_low="+45.68%"
previous_close="4.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.19"
price_per_sales="256.83"
revenue="193000.00"
shares_outstanding="12149000"
short_ratio="3.77"
stock_exchange="NCM"
symbol="GLMD"
volume="27468"
weeks_range_52="2.78 - 7.72"
